Ingraham BS, Huxley SB, Lane CM, Gulati R, et al. Genotype-Guided P2Y(12) Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients: The CHAMP Trial - A Pilot Study and Safety Assessment. Mayo Clin Proc 2024 Nov 26:S0025-6196(24)00307.
PMID: 39601743